About this Podcast: As pharma sponsors continually assesses how to integrate AI into their ways of working, Evinova’s Chief Technology Officer, Sean Connolly, talks about where, how, and when AI is actually making an impact on clinical development based on insights and experiences of working with pharma. Sean share his thoughts on going for low hanging fruit to encourage adoption, what he's seen in terms of pharma companies that are successfully implementing AI across their enterprise, and how h...
Feb 24, 2026•28 min
About this podcast: Recorded at DPHARM 2025, Bayer's Dr Bernhard Glombitza reports on the development, implementation and early impact of their clinical operations reorgnization. He describes how shifting from a traditional hierarchical model to a network of highly empowered teams reduced management layers, broadening the scope of work and changed cross-country operations monitoring. Dr Glombitza details the results of the change thus far, including significant increases in efficiency and reduct...
Jan 29, 2026•13 min
About this podcast: In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact. More specifically, Ms Gershkowitz focuses on: Defining role standards and recruiting the right talent Co-creatin research with patient communities and developing patient-centered outcomes Generating metrics that demonstrate the i...
Jan 29, 2026•25 min
When designing clinical trials, CMOs aim to answer meaningful questions for a plethora of stakeholders. Inherently, this results in study protocols with more measures, biomarkers and data collection that both provides a platform for strategic decision-making but also impacts patient burden, operational foot-print, timelines and cost. In this panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs address how to develop a balanced strategy that takes into account the ambition to an...
Jan 27, 2026•31 min
Investing in developing a durable platform and strategy early leads to fewer delays throughout development. Locking requirements in early and educating teams to approach combination product development holistically lowers the time to development dramatically. In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss how they used platform devices in concert with an internal engagement strategy to speed ...
Jan 27, 2026•30 min
About this podcast: Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma to discuss: Different models and the pros and cons of the deployment models What makes a great patient matching solution Predicting what the future growth of this segment looks like The role of AI in this space
Dec 19, 2025•40 min
About this podcast: Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. For more information, go to IO360summit....
Dec 19, 2025•45 min
About this podcast: Recorded at the 2025 CRAACO meeting, UNC Lineberger’s Comprehensive Cancer Center shares an initiative to allow local HCPs to still provide clinical care to patients but decentralized research elements to the university system, following the FDA’s change in guidance on Form FDA 1572, which stopped requiring local healthcare professionals (HCPs) involved in DCTs to be listed if they’re only performing standard-of-care. Dr J Kaitlin Morrison talks about the process from an init...
Dec 19, 2025•21 min
About this podcast: This podcast, recorded at the 2025 Patients as Partners Europe meeting, addresses how Novo Nordisk is consolidating patient insights to ensure greater knowledge-sharing, data integrity and traceability, addressing the unmet needs of patients, aligning product outcomes with patient expectations, and more. For more information, go to theconferenceforum.org.
Dec 19, 2025•20 min
In this podcast, Kate Woda, Conference Director of the Patients as Partners in Clinical Research conference discusses what attendees can expect at the 13th annual event, including key topic areas, session highlights, presenting companies and more. For more information about the upcoming event, full agenda and speakers, visit patientsaspartnersconference.com .
Dec 18, 2025•5 min
In this podcast, featuring a panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs with recent M&A and partnership experience share those experiences as well as how CMOs of other small to midsize emerging biotech companies can support the conversations and operations that take place throughout the process of business development. Specifically: Different kinds of BD deals to be aware of How the CMO fits into various phases of transactions Appreciating how different c-suite co...
Dec 12, 2025•28 min
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address: Biological and chemical challenges for these therapies Building out scalable manufacturing and a regulatory strategy Hurdles to overc...
Dec 12, 2025•30 min
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° about how to strategically approach hiring FTEs, insourcing, outsourcing and contracting to be appropriately prepared for the different stages of a biotech companies development from preclinical to early stage to late stage trials to commercialization. Specifically: Balancing the mix of hires and outsourcing Hiring for skillsets to enable efficiency without overhiring Reactive vs proactive hiring Building in...
Dec 01, 2025•32 min
While lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles. In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on: Where LNPs potentially fall short Where diff...
Dec 01, 2025•30 min
About this podcast: This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on: Engaging all stakeholders in designing the platform The evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sources Impact of the advanced data analysis capabilities for risk management Review of impact o...
Nov 24, 2025•15 min
About this podcast: Preliminary survey results conducted by the Tufts CSDD focus on the strategic and structural growth of new trial sites and partnerships in bringing trials directly to the local communities. The preliminary survey findings also shed light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape. The significant shift towards bringing clinical trials directly to local communiti...
Nov 24, 2025•16 min
About this podcast: This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center. Dr Rosenberg focuses on: The background and previous data of immune checkpoint blockade as monotherapy and in combination with chemotherapy, in urothelial cancer The potential role of Immunogenic Cell Death and whether it has a clinical impact on patient care and creating an an...
Nov 24, 2025•19 min
About this podcast: This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis. Specifically, this podcast dives deeper into: An introduction to radioligand therapy A focus on PSMA-targeted radionuclide therapy Prelimary work on the relationship between systemic radiation therapy and immune effects at the tumor level For more information, visit IO360summit.com...
Nov 24, 2025•18 min
About this episode: In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: J&J’s approach to patient centricity across the enterprise Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science Moving risk benefit assessments earlier into clinical development and the necessary change management Incorporating multiple streams of data for the purpose of creating medicine...
Nov 19, 2025•26 min
In this podcast, Nicole Murphy, EVP and Head of Pharmaceutical Operations & Technology at Biogen, discusses: Cross-functional collaboration to deliver value How Biogen is using AI to enhance innovation Supply chain simplification Biogen's partnership philosophy as it relates to drug delivery Their recent $2 billion manufacturing investment in the Research Triangle Park And Biogen's acquisition of Alcyone Therapeutics It's an enlightening look into what real leadership in drug delivery, manuf...
Nov 19, 2025•31 min
In this podcast, Kate Woda, Conference Director of the Immuno-Oncology 360° Summit, discusses what attendees can expect at the 12th annual event, including key topic areas, session highlights, presenting companies and more. For more information about the upcoming event, full agenda and speakers, visit IO360Summit.com .
Nov 12, 2025•4 min
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with CMOs and advisory solutions firms about how CMOs can work with consultants and fractional talent to stay on budget while getting the expertise needed. Specifically: Different profiles of fractional consultants What to look for in a consultant and how to ensure alignment with the team Scoping the role of fractional talent and iterating as company needs evolve How to best work with firms representing frac...
Nov 03, 2025•31 min
About this podcast: This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. For more information, go to IO360summit.com .
Oct 24, 2025•18 min
About this podcast: This podcast comes from the 2025 Patients as Partners in Clinical Research conference. This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participation Successful models for empowering local leaders and leveraging commun...
Oct 24, 2025•42 min
About this podcast: Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program. More specifically, Ms Thompson discusses ...
Oct 21, 2025•13 min
About this podcast: This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference. Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing clinical trials, but existing clinical trial infrastructure does not set rural sites up for success. Funded through the Genentech Innovation Fund, Montana State University and Billings Clinic created a rural clinical research readiness toolkit for unaf...
Oct 21, 2025•19 min
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how CMOs can support value creation in biotechs and how that is influenced buy the current biotech financial climate. Specifically: The importance of storytelling and leading thoughtfully Effective prioritization and execution towards the company narrative Balancing the team to be lean while avoiding the potential pitfalls of running lean Balancing the data collected to be interesting...
Sep 30, 2025•30 min
In this podcast from the DPHARM 2024 archives, Biogen discussed how they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to provide access to patients with a clinically validated cognitive assessment who might not otherwise have the foundation to start a conversation with their physician about their cognition. For more information, go to DPHARMconference.com
Sep 26, 2025•21 min
At the March 2025 Patients as Partners conference, Merck presents how they advancing patient and community engagement through targeted initiatives designed to improve trial participation, relevance, and long-term impact. Key topics include: Identifying and addressing patient and community needs Strategies for earning trust and fostering sustained engagement Key collaborations and partnerships driving meaningful change Approaches to developing patient-centered endpoints and outcomes Methods for e...
Sep 26, 2025•19 min
Summary: This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This included: Approaches for aligning internal processes to facilitate the seamless flow of patient insights from early-phase to late-phase teams Suggested tools, including an AI Insights tool designed to centralize and leverage previous patient feedback,...
Aug 22, 2025•18 min
